General Atlantic to invest $100m in India’s Rubicon Research

Photographer: Krisztian Bocsi/Bloomberg

US-based growth equity investor General Atlantic is investing $100 million in Mumbai-based contract research and drug delivery company Rubicon Research Pvt. Ltd, the latter announced on Monday.

The announcement comes close on the heels of private equity firm Everstone revealing last week that it has sold its entire 70 per cent stake in Rubicon to a global private equity player. The firm generated 4.5x multiple and a 92 per cent IRR on its investment in a span of three years.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter